Common-sense combination therapy in refractory immune thrombocytopaenia

Br J Haematol. 2023 Aug;202(4):728-730. doi: 10.1111/bjh.18919. Epub 2023 Jun 7.
No abstract available

Keywords: combination therapy; immune thrombocytopaenia; immunosuppression; refractory; thrombopoietin receptor agonist.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Purpura, Thrombocytopenic, Idiopathic* / drug therapy
  • Recombinant Fusion Proteins
  • Thrombocytopenia*
  • Thrombopoietin

Substances

  • Thrombopoietin
  • Recombinant Fusion Proteins